TAVI in asymptomatic patients with severe aortic stenosis: pros and cons

EuroIntervention 2022;18:793-795. DOI: 10.4244/EIJ-E-22-00043

Philippe Généreux
Philippe Généreux1, MD; Bernard Iung2, MD
1. Gagnon Cardiovascular Institute, Morristown Medical Center, Morristown, NJ, USA; 2. Cardiology Department, AP-HP, Bichat Hospital and INSERM U1148, Université Paris-Cité, Paris, France
Pros: early TAVI, a pre-emptive strategy Philippe Généreux, MD

Aortic stenosis is a progressive disease with an unpredictable evolution. While some phases of the disease are latent, the left ventricle and other cardiac structures are constantly exposed to an increasing overload of pressure, with silent cardiac damage (structural and functional) accumulating over time. Often, the expression of symptoms among patients with progressive aortic stenosis appears at a point when a second or third cardiac “disease” occurs, such as a decrease in left ventricle function, diastolic dysfunction, or atrial fibrillation, which all could ...

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Long-term risk of unplanned percutaneous coronary intervention after transcatheter aortic valve replacement

Latest news